The University of British Columbia
UBC - A Place of Mind
The University of British Columbia
Faculty of Medicine
  • Home
  • Admissions
  • About
    • Strategic Plan
    • Vision & Values
    • Land Acknowledgement
    • Indigenous Health
    • Leadership
    • Academic & Research Units
    • Campuses
    • Facts & Figures
    • Careers
    • Contact
  • News
    • Feature Stories
    • Pathways Magazine
    • The Next Big Question
  • Education
    • Programs
    • Faculty Development
    • Health Education Scholarship
    • Continuing Professional Development
  • Research
    • Priority Areas
    • Canada’s Immuno-Engineering and Biomanufacturing Hub
    • COVID-19 Clinical Research Coordination Initiative
    • Academy of Translational Medicine
    • Edwin S.H. Leong Centre for Healthy Aging
    • Centres & Institutes
    • National Prizes
  • Giving
    • Impact of Giving
    • By the Numbers
    • Ways to Give
    • Webinar Series
    • Contact Us
  • Prospective Students
  • Current Learners
    • Policies & Procedures
    • Respectful Environments, Equity, Diversity & Inclusion
    • Mistreatment Help
    • MD & Undergrad Research
    • Summer Student Research Program
    • Multidisciplinary Research Program in Medicine
    • Grad & Postdoc Education
  • Faculty & Staff
  • Clinical Faculty
    • Becoming Clinical Faculty
    • Appointment Policy & Compensation Terms
    • Teaching Tracking & Payment System
    • Services & Perks
    • Career Development
    • Awards
    • Celebrating Clinical Faculty
    • Advisory Council
    • Contacts
  • Alumni
» Home » News » UBC scientist finds a key to cancer cells’ resilience

Contact

Communications
UBC Faculty of Medicine
Email: communications.med@ubc.ca
Office: 604.822.2421

UBC scientist finds a key to cancer cells’ resilience

By bkladko | March 26, 2015

Poul Sorensen. Photo: BC Cancer Foundation

Poul Sorensen. Photo: BC Cancer Foundation

A Faculty of Medicine scientist has found a way that tumour cells cope — and even thrive — under harsh conditions.

Tumours that produce more stress granules — clusters of mRNA that accumulate in cells’ inner compartments — are more likely to metastasize, according to an article by Poul Sorensen, a Professor in the Department of Pathology and Laboratory Medicine, published March 17 in the Journal of Cell Biology.

Stress granules, which is where cells stash their mRNA when they need to suspend protein synthesis, are produced by normal cells, too, allowing them to survive stress, caused by a variety of conditions, including lack of nutrients or exposure to toxic chemicals. But if the formation of those granules can be inhibited in cancer cells, it could prevent tumours from spreading throughout the body.

Dr. Sorensen, a Distinguished Scientist at the BC Cancer Agency, found that stressed-out cancer cells need a protein called YB-1 to stimulate production of another protein, G3BP1, which is critical for the assembly of stress granules.

Dr. Sorensen and his team found that in vitro cancer cells that made YB-1 carried more stress granules than those that lacked it. They also found that tumours  with G3BP1 metastasized in mice, while tumours lacking G3BP1 lost their metastatic capacity.

Contact Information

Communications
UBC Faculty of Medicine
Email: communications.med@ubc.ca
Office: 604.822.2421
Faculty of Medicine
317 - 2194 Health Sciences Mall
Vancouver, BC Canada V6T 1Z3
Tel 604 822 2421
Website www.med.ubc.ca
Find us on
    
Back to top
The University of British Columbia
  • Emergency Procedures |
  • Terms of Use |
  • Copyright |
  • Accessibility